Visual function in menopause: The role of hormone replacement therapy

Secondo Guaschino, Eva Grimaldi, Andrea Sartore, Raffaela Mugittu, Francesco Mangino, Paolo Bortoli, Stefano Pensiero, Agatino Vinciguerra, Paolo Perissutti

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective: To assess the effects of hormone replacement therapy (HRT) on visual function after menopause. Design: This study was conducted on 80 postmenopausal women aged 52 to 70 years. Women were randomly divided into two groups: 40 women were treated by oral HRT (equine conjugated estrogens 0.625 mg/day + dydrogesterone 5 mg/day in a continuous combined regimen), and 40 women were not treated with hormones (control group). Each woman underwent a contrast sensitivity test, a Schirmer test, and an evaluation of intraocular pressure before starting the study and 1 year after the beginning of the study. Statistical analysis was performed by Student's t test and Fisher's exact test. Results: Contrast sensitivity function was significantly improved in all spatial frequencies (1.5, 3, 6, and 12 cycles per degree) with the exception of 18 cycles per degree in the HRT group 1 year after the beginning of treatment, whereas the control group demonstrated significant impairment at the lowest spatial frequencies (1.5, 3, and 6 cycles per degree). Tear production was significantly improved in the HRT group 1 year after the beginning of treatment, and intraocular pressure was similar in the two groups before and after the beginning of the study. Conclusions: HRT improves visual function, promoting a better contrast sensitivity and a higher tear production, but does not modify intraocular pressure.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalMenopause
Volume10
Issue number1
DOIs
Publication statusPublished - Jan 2003

Fingerprint

Hormone Replacement Therapy
Menopause
Contrast Sensitivity
Intraocular Pressure
Tears
Dydrogesterone
Conjugated (USP) Estrogens
Control Groups
Hormones
Students
Therapeutics

Keywords

  • Contrast sensitivity
  • Hormone replacement therapy
  • Intraocular pressure
  • Menopause
  • Tear secretion

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Guaschino, S., Grimaldi, E., Sartore, A., Mugittu, R., Mangino, F., Bortoli, P., ... Perissutti, P. (2003). Visual function in menopause: The role of hormone replacement therapy. Menopause, 10(1), 53-57. https://doi.org/10.1097/00042192-200310010-00009

Visual function in menopause : The role of hormone replacement therapy. / Guaschino, Secondo; Grimaldi, Eva; Sartore, Andrea; Mugittu, Raffaela; Mangino, Francesco; Bortoli, Paolo; Pensiero, Stefano; Vinciguerra, Agatino; Perissutti, Paolo.

In: Menopause, Vol. 10, No. 1, 01.2003, p. 53-57.

Research output: Contribution to journalArticle

Guaschino, S, Grimaldi, E, Sartore, A, Mugittu, R, Mangino, F, Bortoli, P, Pensiero, S, Vinciguerra, A & Perissutti, P 2003, 'Visual function in menopause: The role of hormone replacement therapy', Menopause, vol. 10, no. 1, pp. 53-57. https://doi.org/10.1097/00042192-200310010-00009
Guaschino S, Grimaldi E, Sartore A, Mugittu R, Mangino F, Bortoli P et al. Visual function in menopause: The role of hormone replacement therapy. Menopause. 2003 Jan;10(1):53-57. https://doi.org/10.1097/00042192-200310010-00009
Guaschino, Secondo ; Grimaldi, Eva ; Sartore, Andrea ; Mugittu, Raffaela ; Mangino, Francesco ; Bortoli, Paolo ; Pensiero, Stefano ; Vinciguerra, Agatino ; Perissutti, Paolo. / Visual function in menopause : The role of hormone replacement therapy. In: Menopause. 2003 ; Vol. 10, No. 1. pp. 53-57.
@article{a31cae8556fe48b3a6ebae4079ef2430,
title = "Visual function in menopause: The role of hormone replacement therapy",
abstract = "Objective: To assess the effects of hormone replacement therapy (HRT) on visual function after menopause. Design: This study was conducted on 80 postmenopausal women aged 52 to 70 years. Women were randomly divided into two groups: 40 women were treated by oral HRT (equine conjugated estrogens 0.625 mg/day + dydrogesterone 5 mg/day in a continuous combined regimen), and 40 women were not treated with hormones (control group). Each woman underwent a contrast sensitivity test, a Schirmer test, and an evaluation of intraocular pressure before starting the study and 1 year after the beginning of the study. Statistical analysis was performed by Student's t test and Fisher's exact test. Results: Contrast sensitivity function was significantly improved in all spatial frequencies (1.5, 3, 6, and 12 cycles per degree) with the exception of 18 cycles per degree in the HRT group 1 year after the beginning of treatment, whereas the control group demonstrated significant impairment at the lowest spatial frequencies (1.5, 3, and 6 cycles per degree). Tear production was significantly improved in the HRT group 1 year after the beginning of treatment, and intraocular pressure was similar in the two groups before and after the beginning of the study. Conclusions: HRT improves visual function, promoting a better contrast sensitivity and a higher tear production, but does not modify intraocular pressure.",
keywords = "Contrast sensitivity, Hormone replacement therapy, Intraocular pressure, Menopause, Tear secretion",
author = "Secondo Guaschino and Eva Grimaldi and Andrea Sartore and Raffaela Mugittu and Francesco Mangino and Paolo Bortoli and Stefano Pensiero and Agatino Vinciguerra and Paolo Perissutti",
year = "2003",
month = "1",
doi = "10.1097/00042192-200310010-00009",
language = "English",
volume = "10",
pages = "53--57",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Visual function in menopause

T2 - The role of hormone replacement therapy

AU - Guaschino, Secondo

AU - Grimaldi, Eva

AU - Sartore, Andrea

AU - Mugittu, Raffaela

AU - Mangino, Francesco

AU - Bortoli, Paolo

AU - Pensiero, Stefano

AU - Vinciguerra, Agatino

AU - Perissutti, Paolo

PY - 2003/1

Y1 - 2003/1

N2 - Objective: To assess the effects of hormone replacement therapy (HRT) on visual function after menopause. Design: This study was conducted on 80 postmenopausal women aged 52 to 70 years. Women were randomly divided into two groups: 40 women were treated by oral HRT (equine conjugated estrogens 0.625 mg/day + dydrogesterone 5 mg/day in a continuous combined regimen), and 40 women were not treated with hormones (control group). Each woman underwent a contrast sensitivity test, a Schirmer test, and an evaluation of intraocular pressure before starting the study and 1 year after the beginning of the study. Statistical analysis was performed by Student's t test and Fisher's exact test. Results: Contrast sensitivity function was significantly improved in all spatial frequencies (1.5, 3, 6, and 12 cycles per degree) with the exception of 18 cycles per degree in the HRT group 1 year after the beginning of treatment, whereas the control group demonstrated significant impairment at the lowest spatial frequencies (1.5, 3, and 6 cycles per degree). Tear production was significantly improved in the HRT group 1 year after the beginning of treatment, and intraocular pressure was similar in the two groups before and after the beginning of the study. Conclusions: HRT improves visual function, promoting a better contrast sensitivity and a higher tear production, but does not modify intraocular pressure.

AB - Objective: To assess the effects of hormone replacement therapy (HRT) on visual function after menopause. Design: This study was conducted on 80 postmenopausal women aged 52 to 70 years. Women were randomly divided into two groups: 40 women were treated by oral HRT (equine conjugated estrogens 0.625 mg/day + dydrogesterone 5 mg/day in a continuous combined regimen), and 40 women were not treated with hormones (control group). Each woman underwent a contrast sensitivity test, a Schirmer test, and an evaluation of intraocular pressure before starting the study and 1 year after the beginning of the study. Statistical analysis was performed by Student's t test and Fisher's exact test. Results: Contrast sensitivity function was significantly improved in all spatial frequencies (1.5, 3, 6, and 12 cycles per degree) with the exception of 18 cycles per degree in the HRT group 1 year after the beginning of treatment, whereas the control group demonstrated significant impairment at the lowest spatial frequencies (1.5, 3, and 6 cycles per degree). Tear production was significantly improved in the HRT group 1 year after the beginning of treatment, and intraocular pressure was similar in the two groups before and after the beginning of the study. Conclusions: HRT improves visual function, promoting a better contrast sensitivity and a higher tear production, but does not modify intraocular pressure.

KW - Contrast sensitivity

KW - Hormone replacement therapy

KW - Intraocular pressure

KW - Menopause

KW - Tear secretion

UR - http://www.scopus.com/inward/record.url?scp=0037507409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037507409&partnerID=8YFLogxK

U2 - 10.1097/00042192-200310010-00009

DO - 10.1097/00042192-200310010-00009

M3 - Article

C2 - 12544677

AN - SCOPUS:0037507409

VL - 10

SP - 53

EP - 57

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 1

ER -